Aethlon Medical (AEMD) Liabilities and Shareholders Equity (2011 - 2026)

Aethlon Medical's Liabilities and Shareholders Equity history runs 16 years deep, the most recent figure standing at $6.3 million for Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 13.95% year-over-year to $6.3 million; the trailing twelve-month figure through Mar 2026 stood at $27.0 million (down 20.87% YoY), and the FY2026 full-year result was $6.3 million, down 13.95% from the prior year.
• Liabilities and Shareholders Equity was $6.3 million for Q1 2026 at Aethlon Medical, down from $8.1 million in the prior quarter.
• Over the last five years, Liabilities and Shareholders Equity for AEMD reached as high as $23.0 million in Q3 2022 and fell as low as $5.3 million in Q2 2025.
• Median Liabilities and Shareholders Equity over the past 5 years was $10.4 million (2023), compared with a mean of $12.1 million.
• Across the five-year window, Liabilities and Shareholders Equity jumped 82.0% in 2022 and plunged 53.52% in 2025, its largest moves.
• Over 5 years, Liabilities and Shareholders Equity stood at $20.7 million in 2022, then slumped by 49.64% to $10.4 million in 2023, then sank by 37.48% to $6.5 million in 2024, then increased by 23.47% to $8.1 million in 2025, then retreated by 21.4% to $6.3 million in 2026.
• Business Quant data shows AEMD's Liabilities and Shareholders Equity at $6.3 million in Q1 2026, $8.1 million in Q4 2025, and $7.3 million in Q3 2025.